Ocugen (MEX:OCGN) Total Operating Expense: MXN1,292.92 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OCGN Ocugen Inc MEX:OCGN
35 GF Score
Price MXN20.68
GF Value MXN13.07
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ocugen Total Operating Expense?

Ocugen MEX:OCGN 35 Total Operating Expense is MXN1,292.92 Mil as of Mar. 2026. GuruFocus rates MEX:OCGN with a GF Score™ of 35/100 and a GF Value™ of MXN13.07 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Ocugen's Total Operating Expense for the three months ended in Mar. 2026 was MXN349.33 Mil. Ocugen's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was MXN1,292.92 Mil.

Ocugen Total Operating Expense Related Terms

Ocugen Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Ocugen's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocugen Total Operating Expense Chart

Ocugen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,190.39 1,785.03 1,214.80 1,226.57 1,212.31

Ocugen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 326.96 285.60 355.46 302.53 349.33
MEX:OCGN
35GF Score
Ocugen Inc MEX:OCGN
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ocugen Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1,292.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of MXN1,292.92 Mil mean?
Ocugen (MEX:OCGN) has a Total Operating Expense of MXN1,292.92 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ocugen and its competitors.
Is Ocugen's Total Operating Expense too high?
Ocugen's current Total Operating Expense is MXN1,292.92 Mil. Overall, Ocugen has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ocugen's Total Operating Expense compare to EVMN and PBYI?
Ocugen's Total Operating Expense of MXN1,292.92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ocugen and its competitors. Ocugen's current Total Operating Expense is MXN1,292.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocugen stock overvalued right now?
Based on GuruFocus' analysis, Ocugen (MEX:OCGN) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN13.07, compared to a current price of MXN20.68 — trading 58.2% above its estimated fair value. The current Total Operating Expense is MXN1,292.92 Mil. Ocugen's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Ocugen (MEX:OCGN), the current Total Operating Expense is MXN1,292.92 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ocugen (MEX:OCGN) Overvalued in 2026?

Based on GuruFocus' analysis, Ocugen stock appears to be overvalued. The current stock price of MXN20.68 is trading 58.2% above its estimated GF Value™ of MXN13.07. GuruFocus considers Ocugen to be Significantly Overvalued.

Key valuation signals for MEX:OCGN:

  • Total Operating Expense: MXN1,292.92 Mil
  • GF Value™: MXN13.07 vs. price of MXN20.68 (58.2% above fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the MEX:OCGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ocugen Business Description

Other Exchanges OCGN:USA2H51:Germany
Address 11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
35GF Score

Get the complete analysis for MEX:OCGN

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN20.68
Price
MXN13.07
GF Value